TY - JOUR
T1 - Low cell number proteomic analysis using in-cell protease digests reveals a robust signature for cell cycle state classification
AU - Kelly, Van
AU - Al-Rawi, Aymen
AU - Lewis, David
AU - Kustatscher, Georg
AU - Ly, Tony
N1 - Funding Information:
This work was supported by a Sir Henry Dale Fellowship to T. L. (Wellcome Trust & Royal Society [206211/Z/17/Z]), a Darwin Trust PhD Studentship to A. A., an EASTBIO PhD Studentship to D. L., and a Medical Research Council Career Development Award to G. K.
Funding Information:
Acknowledgments—The work was supported by the Wellcome Centre for Cell Biology (WCB) core facilities (Wellcome Trust 203149), and funding for instrumentation, including equipment grants to the WCB Proteomics Core (091020) and the flow facilities. We thank for the valuable feedback and discussions with colleagues in the WCB and the University of Edinburgh, including Fiona Rossi (Scottish Centre for Regenerative Medicine), Christos Spanos (WCB), and Shaun Webb (WCB).
Funding Information:
& Royal Society [206211/Z/17/Z]), a Darwin Trust PhD Studentship to A. A., an EASTBIO PhD Studentship to D. L., and a Medical Research Council Career Development Award to G. K.
Publisher Copyright:
© 2021 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.
PY - 2022/1/1
Y1 - 2022/1/1
N2 - Comprehensive proteome analysis of rare cell phenotypes remains a significant challenge. We report a method for low cell number mass spectrometry (MS)-based proteomics using protease digestion of mildly formaldehyde-fixed cells in cellulo, which we call the 'in-cell digest'. We combined this with AMPL (Averaged MS1 Precursor Library Matching) to quantitatively characterise proteomes from low cell numbers of human lymphoblasts. 4,500 proteins were detected from 2,000 cells and 2,500 proteins were quantitated from 200 lymphoblasts. The ease of sample processing and high sensitivity makes this method exceptionally suited for the proteomic analysis of rare cell states, including immune cell subsets and cell cycle subphases. To demonstrate the method, we characterised the proteome changes across 16 cell cycle states isolated from an asynchronous TK6 human lymphoblast culture, avoiding synchronization. States included late mitotic cells present at extremely low frequency. We identified 119 pseudoperiodic proteins (PsPs) that vary across the cell cycle. Clustering of the PsPs showed abundance patterns consistent with 'waves' of protein degradation in late S, at the G2&M border, mid-mitosis and at mitotic exit. These clusters were distinguished by significant differences in predicted nuclear localization and interaction with the APC/C. The dataset also identifies putative APC/C substrates in mitosis and the temporal order in which they are targeted for degradation. We demonstrate that a protein signature made of these 119 high confidence cell cycle regulated proteins can be used to perform unbiased classification of proteomes into cell cycle states. We applied this signature to 296 proteomes that encompass a range of quantitation methods, cell types, and experimental conditions. The analysis confidently assigns a cell cycle state for 49 proteomes, including correct classification for proteomes from synchronized cells. We anticipate this robust cell cycle protein signature will be crucial for classifying cell states in single cell proteomes.
AB - Comprehensive proteome analysis of rare cell phenotypes remains a significant challenge. We report a method for low cell number mass spectrometry (MS)-based proteomics using protease digestion of mildly formaldehyde-fixed cells in cellulo, which we call the 'in-cell digest'. We combined this with AMPL (Averaged MS1 Precursor Library Matching) to quantitatively characterise proteomes from low cell numbers of human lymphoblasts. 4,500 proteins were detected from 2,000 cells and 2,500 proteins were quantitated from 200 lymphoblasts. The ease of sample processing and high sensitivity makes this method exceptionally suited for the proteomic analysis of rare cell states, including immune cell subsets and cell cycle subphases. To demonstrate the method, we characterised the proteome changes across 16 cell cycle states isolated from an asynchronous TK6 human lymphoblast culture, avoiding synchronization. States included late mitotic cells present at extremely low frequency. We identified 119 pseudoperiodic proteins (PsPs) that vary across the cell cycle. Clustering of the PsPs showed abundance patterns consistent with 'waves' of protein degradation in late S, at the G2&M border, mid-mitosis and at mitotic exit. These clusters were distinguished by significant differences in predicted nuclear localization and interaction with the APC/C. The dataset also identifies putative APC/C substrates in mitosis and the temporal order in which they are targeted for degradation. We demonstrate that a protein signature made of these 119 high confidence cell cycle regulated proteins can be used to perform unbiased classification of proteomes into cell cycle states. We applied this signature to 296 proteomes that encompass a range of quantitation methods, cell types, and experimental conditions. The analysis confidently assigns a cell cycle state for 49 proteomes, including correct classification for proteomes from synchronized cells. We anticipate this robust cell cycle protein signature will be crucial for classifying cell states in single cell proteomes.
KW - single-cell proteome heterogeneity
KW - FACS
KW - formaldehyde
KW - PRIMMUS
KW - MS1-based feature matching
U2 - 10.1016/j.mcpro.2021.100169
DO - 10.1016/j.mcpro.2021.100169
M3 - Article
C2 - 34742921
SN - 1535-9476
VL - 21
JO - Molecular & Cellular Proteomics (MCP)
JF - Molecular & Cellular Proteomics (MCP)
IS - 1
M1 - 100169
ER -